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Clinical Relevance 
Scientific rationale for study: Matrix metalloproteinase (MMP)-8 is the major collagenase 
in gingival crevicular fluid and its levels in gingival tissues and oral fluids are significantly 
elevated in periodontitis. It is secreted in its inactive pro-form and gets activated by auto- or 
bacterial degradation.  
 
Principal findings: The fragments of salivary MMP-8 were elevated in both localized (early) 
and generalized (advanced) forms of periodontitis. Treponema denticola chymotrypsin-like 
protease can activate the inactive pro-MMP-8 and form MMP-8fragments. 
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Practical implications: Future diagnostic adjunctive quantitative MMP-8 point-of-
care/chair-side technologies need to utilize MMP-8 antibodies selective for MMP-8 
activation cascade and fragments. 
 
Abstract 
Aim: To investigate the molecular forms of salivary matrix metalloproteinase (MMP)-8 in 
relation to periodontitis.  
Materials and Methods: Molecular forms, degree of activation, and fragmentation of 
neutrophilic and mesenchymal type MMP-8 isoforms were analyzed from salivary samples of 
81 subjects with generalized periodontitis, 63 subjects with localized periodontitis, and 79 
subjects without pocket teeth, by using western-immunoblots with computer quantitation. In 
addition, human recombinant proMMP-8 was in vitro activated by Treponema denticola 
chymotrypsin-like protease (Td-CTLP), sodium hypochlorite (NaOCl, 1 mM, oxidant), or 
amino phenyl mercuric acetate (APMA, 1 mM).  
Results: In saliva of periodontitis-affected individuals, MMP-8 is found in multiple forms, 
i.e., complexes, active and pro-forms of neutrophilic and mesenchymal-type MMP-8, and 
especially 20-27 kDa fragments. The quantity of these fragments was elevated in both 
localized and generalized forms of periodontitis. Moreover, the tested activators (Td-CTLP, 
NaOCl, and APMA) activated inactive proMMP-8, resulting in fragments of 20-27 kDa, in 
vitro, and salivary concentrations of T. denticola correlated significantly with salivary levels 
of fragmented MMP-8.  
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Conclusion: The present results indicate that during the development and progression of 
periodontitis, MMP-8 appears as activated and fragmented, and treponemal proteases most 
likely play role in this cascade.  
 
Introduction 
In health, matrix metalloproteinases (MMPs) function in tissue development, homeostasis 
and remodeling, cell migration and wound healing, immune cell activation, and antimicrobial 
defense, and their activities are regulated by tissue inhibitors of matrix metalloproteinases. 
Their pathologically elevated expressions, however, may lead to irreversible tissue 
destruction, as in tumor angiogenesis and metastasis, vascular diseases, and periodontitis 
(Rohani and Parks, 2015). 
In the oral cavity, various cell types express and secrete MMPs. Neutrophils, which form a 
continuous barrier in the gingival crevice between bacterial biofilm and the epithelium, 
degranulate MMP-8 (collagenase-2 or neutrophilic collagenase), being of major importance 
in etiopathogenesis of periodontal disease (Alfakry et al., 2016). In periodontitis, MMP-8 is 
the major collagenase in periodontal tissues and over 90% of the collagenase activity in 
gingival crevicular fluid (GCF), saliva, and mouthrinse originates from MMP-8 (Sorsa et al., 
2016). While MMP-8 is one of the most important degradative enzymes in pathogenesis of 
periodontal disease at pathologically elevated levels, its total absence disrupts host-defensive 
response, which  associates with progression of periodontitis and systemic inflammation, as 
demonstrated in a MMP-8 knockout-mice model (Kuula et al., 2009). Elevated levels of 
activated MMP-8 in oral fluids have been proposed as diagnostic markers of periodontitis 
(Gursoy et al., 2010, 2018; Ebersole et al., 2015; Sorsa et al., 2016). 
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By using immunodetection methods, MMP-8 can be found in several molecular forms in 
GCF and peri-implant sulcus fluid; these include complexes at sizes of >110 kDa, latent (pro) 
and active forms of neutrophilic MMP-8 at 70-80 kDa, mesenchymal-type collagenase at 50-
65 kDa with latent (pro) and active forms, and fragments at 20-30 kDa (Hasty et al., 1986; 
Ding et al., 1997; Palosaari et al., 2000; Kiili et al., 2002; Reynaud af Geijersstam et al., 
2005). It has been shown that Treponema denticola, a major periodontitis-associated 
bacterium, can activate proMMP-2 with its chymotrypsin-like protease (Miao et al., 2011). 
Active neutrophilic 55 kDa MMP-8 is considered one major form in periodontitis (Romanelli 
et a., 1999; Sorsa et al., 2010). Detecting high levels of active MMP-8 in saliva has a strong 
diagnostic ability in comparison to methods that detect total MMP-8 levels (Gursoy et al., 
2010). Although molecular forms of MMP-8 have been demonstrated in GCF and peri-
implant sulcus fluid (Kiili et al., 2002; Kivelä-Rajamäki et al., 2003; Sorsa et al., 2010), to 
our knowledge, relationships of different molecular forms of salivary MMP-8 fractions to 
periodontitis have not been studied yet. Moreover, the activation of proMMP-8 by T. 
denticola chymotrypsin-like protease (Td-CTLP) has not been demonstrated before. 
According to our hypothesis, in periodontitis, secreted MMP-8 is subjected to auto- or 
bacterial degradation, and MMP-8 fragments become detectable as early diagnostic markers 
of active disease and disease severity. With this background, the aim was to examine the 
molecular forms of MMP-8 in saliva, and the degree of activation and fragmentation of 
MMP-8 in relation to periodontitis. 
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Material and Methods 
Activation of human recombinant proMMP-8 by Td-CTLP, sodium hypochlorite 
(NaOCl), and Amino Phenyl Mercuric Acetate (APMA) 
Purified PMN MMP-8 was prepared as described by Hanemaaijer et al. (1997). Human 
proMMP-8 (20 µg) was treated with Td-CTLP, as described by Sorsa et al. (1992), 1 mM 
NaOCl (Pharmacy of University of Helsinki, Helsinki, Finland), and 1 mM APMA (Sigma, 
St Luis, MO, USA)  and the activations were monitored by western-immunoblotting (Saari et 
al., 1990; Ding et al., 1996).   
 
Saliva samples 
The paraffin-stimulated saliva samples came from participants of the Southern Finland 
district of the national Finnish Health 2000 survey (BRIF8901) and the clinical data from oral 
and radiographic examinations of the survey participants are described in the report of the 
National Public Health Institute (http://www.terveys2000.fi/indexe.html). All participants 
gave written informed consent, and study protocols were approved by the Ethical Committee 
for Epidemiology and Public Health of the Hospital District of Helsinki and Uusimaa, 
Finland (BRIF8901, 407/E3/2000/terveys2000). 
Digital panoramic radiographs were used to determine the alveolar bone loss (Gursoy et al., 
2013). Radiographs were taken with a dental panoramic x‐ray machine (imaging values 
between 58–68 kV and 4–10 mA, PM 2002 CC proline apparatus; Planmeca, Helsinki, 
Finland) and bone levels of each tooth (mesial and distal surfaces and on the furcation areas 
of molar teeth) were analyzed by a specialist in oral radiology using an inbuilt measuring tool 
of Dimaxis software (Planmeca). The Advisory Board for Radiation Safety approved 
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radiographical examination protocols and the Radiation and Nuclear Safety Authority and the 
Ethics Committees for Human Studies of the National Public Health Institute and the Institute 
of Epidemiology and National Health, Finland granted the safety licenses. 
The samples were transported in carbonic acid ice and immediately frozen at −70°C until 
further use.  When the saliva samples were thawed for the first time, they were centrifuged at 
9300 g for 5 min, and the supernatants were used for the biochemical assays. 
A total of 223 saliva samples, collected from 81 subjects with generalized periodontitis (GP) 
[14 or more teeth with ≥4 mm probing pocket depth (PPD)], 63 subjects with localized 
periodontitis (LP with two subgroups; LP1: 2 teeth with PPD of ≥4 mm, and LP2: 7 teeth 
with PPD of ≥ 4 mm), and 79 subjects without pocket teeth (control), were included in the 
present study. Mean bone loss levels were 33.3±41.4 mm for GP, 11.1±12.5 mm for LP1, 
18.3±26.2 for LP2, and 3.5±5.4 mm for the control group (Gursoy et al., 2013). All patients 
in the GP and LP groups showed bone loss and the patient was used as the unit of analysis. 
All Health 2000 survey subjects who fit into above mentioned groups were included in the 
study. Mean age (with minimum-maximum values) of the participants in four periodontal 
groups were as follows: 49.6 (41-60) years for GP, 48.0 (40-60) years for LP1, 49.4 (41-59) 
years for LP2, and 47.9 (40-60) years for the control group. Percentages of smokers were 
56.6% for GP, 25.0% for LP1, 34.5% for LP2, and 23.5% for the control group. Male 
percentage was 60.2% for the GP, 41.7% for LP1, 41.4% for LP2, and 35.8% for the control 
group.  
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Immunoblotting of salivary MMP-8 
All samples were analyzed together and the laboratory staff was unaware of the study groups 
in which the samples belong to. For detecting the molecular forms of salivary MMP-8, a 
modified method of the enhanced chemiluminescence (ECL) Western immunoblotting kit 
(GE Healthcare, Amersham, UK) was used according to the protocol recommended by the 
manufacturer (Lauhio et al., 1994; Hanemaajier et al., 1997). Briefly, 14 µl of saliva were 
mixed with Laemmli’s buffer without the reducing reagent and heated for 5 min, and protein 
separations were performed with 11% sodium dodecyl sulphate (SDS)-polyacrylamide gels. 
After electrophoresis, the proteins were electrotransferred onto nitrocellulose membranes 
(Protran, Whatman GmbH, Dassel, Germany), which were incubated overnight with a 
primary polyclonal antibody, anti-MMP-8 (Lauhio et al., 1994; Hanemaaijer et al., 1997). 
Target detection was performed according to the manufacturer’s protocol. The quantitation of 
immunoblots was performed by using the GS-700 Imaging Densitometer Scanner and the 
Bio-Rad Quantity One program (Bio-Rad, Hercules, CA, USA). 
 
Detection of Treponema denticola 
Salivary T. denticola levels were available for the control and GP groups from our previous 
study (Hyvärinen et al., 2009). The analysis of T. denticola was performed using a single 
copy gene–based real-time PCR (Hyvärinen et al., 2009). The results are expressed as 
concentrations using genomes per milliliter (GE/ml). 
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Follow-up Study 
A part of the participants of the national Finnish Health 2000 survey (BRIF8901), who were 
at the age of 18 or older in 2000, were invited to a follow-up study, Health 2011 survey. Of 
the 223 participants of Health 2000 survey, whose saliva samples were analyzed in the 
present study, 120 participated to clinical oral health examination in the Health 2011 survey 
as well. A detailed description of the Health 2011 survey and its clinical oral examinations 
can be found elsewhere (Suominen et al., 2018). Study protocols were approved by the 
Ethical Committee for Epidemiology and Public Health of the Hospital District of Helsinki 
and Uusimaa, Finland and all participants gave informed consent (45/13/03/00/11 for the 
Health 2011 survey). 
To define the predictive capabilities of each molecular form of MMP-8 present in saliva, 
salivary levels of MMP-8 forms were first divided into tertiles and then the participants were 
grouped according their tertile scores. Number of teeth with deepened pockets (PPD ≥6 mm) 
in 2011 was taken as outcome variable.  
 
Statistical analyses 
All statistical analyses were performed with the SPSS statistical program (version 23.0; IBM 
Armonk, New York, USA). The data distributions of MMP-8 fraction levels were skewed, 
therefore, non-parametric tests were applied. The Kruskal-Wallis H (for multiple 
comparisons) and Mann-Whitney U tests were used for comparing the levels of the molecular 
forms of MMP-8 between the four periodontal groups. The Spearman test was used to 
analyze the correlations between different forms of MMP-8 and salivary T. denticola levels. 
A statistical significance was defined as a p-value <0.05. 
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Results 
Purified MMP-8 was in part autofragmented and self-activated. Human 70-80 kDa proMMP-
8 was converted to its 50-60 kDa active forms by tested Td-CTLP, HOCl, and APMA, and 
further induced to the fragmented lower molecular size of 20-27 kDa fragments (Fig. 1 A-C). 
The molecular forms, activations, and fragments of salivary MMP-8 are given in Figure 2. 
The relative levels of MMP-8 complexes at >110 kDa were higher in LP2 group than in 
controls (p=0.032). No difference was observed in pro-forms of neutrophilic MMP-8. The 
active form of neutrophilic MMP-8 was lowest in LP1 group, in comparison to the control 
(p=0.033) and GP (p=0.002) groups. Neither the pro-form nor the active form of 
mesenchymal MMP-8 differed between the periodontal groups. The 20-27 kDa fragments of 
MMP-8 were elevated in LP1 (p<0.001), LP2 (p<0.001), and GP (p<0.001) groups, when 
compared with the control group (Figure 3). 
Salivary levels of T. denticola were 1.64x10
4
 GE/ml for the GP group and 5.64x10
3
 GE/ml 
for the controls. There were significant correlations between fragments of MMP-8 and T. 
denticola (Spearman's rho=189, p=0.016), and between the active form of mesenchymal 
MMP-8 and T. denticola (Spearman's rho=207, p=0.008). 
Figure 4 presents the ROC curves for discriminating the periodontitis and control groups. The 
20-27 kDa fragments of MMP-8 were able to distinguish the subjects with and without 
periodontitis and provided AUCs larger than 0.7 (p<0.001).  
GP patients in the highest tertiles of fragmented (p=0.021) form of MMP-8 had a higher 
number of teeth with deepened pockets (PPD ≥6 mm) in the follow-up Health 2011 study, in 
comparison to those who were in the lowest tertiles of these molecular forms. 
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Discussion 
In the present study, we demonstrated that MMP-8 present in saliva can be observed in 
complex, active and pro neutrophilic, and active and pro mesenchymal forms, as well as in 
low molecular weight (20-27 kDa) fragments. Among these molecular forms, the fragments 
of salivary MMP-8 were elevated in both localized (early) and generalized (advanced) forms 
of periodontitis.  
This is the first study to characterize the molecular forms and fragmentation of salivary 
MMP-8 in periodontitis. A previous study, dealing with molecular forms and levels of MMP-
8 in GCF, demonstrated increases in active forms of neutrophilic and mesenchymal MMP-8 
during periodontitis, whereas fragments of MMP-8 were barely detectable (Kiili et al., 2002). 
In another study, using peri-implantitis sulcus fluid, all six forms of MMP-8 were found at 
higher levels in peri-implant mucositis and peri-implantitis cases in comparison to those in 
healthy controls (Kivelä-Rajamäki et al., 2003). The salivary profile of MMP-8 in 
periodontitis seems to differ, at least partly, from its profile in GCF during periodontitis and 
in peri-implant sulcular fluid during peri-implantitis. 
Neutrophilic MMP-8 is secreted, or degranulated, as a 75 kDa molecule in pro-form and is 
reduced to its active form at 57 kDa (Hasty et al., 2006). The 20-27 kDa fragments of MMP-8 
are degradation end-products of 57 kDa neutrophilic MMP-8 activation and are without 
collagenase activity (Hasty et al., 1986). Release, activation, and fragmentation of MMP-8 
upon degranulation from neutrophils is regulated by bacteria (Reynaud af Geijersstam et al., 
2005), especially by periodontitis-associated pathogens (Ding et al., 1996; 1997). Bacterial 
enzymes convert pro neutrophilic MMP-8 to its active form and matrilysin-1 (MMP-7) is 
responsible for its proteolytical cleavage (Sorsa et al., 1992; Dozier et al., 2006). MMP-8 can 
also be activated by oxidative mechanisms without having a reduction in its molecular weight 
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(Saari et al., 1990). MMP-8 fragments, on the other hand, are end-products of auto- and 
bacterial degradation of degranulated 57 kDa MMP-8 (Reynaud af Geijersstam et al., 2005; 
Hasty et al., 2006). The degradation of 57 kDa MMP-8 by T. denticola was demonstrated in 
this study as well. Moreover, salivary levels of fragmented MMP-8 correlated significantly 
with salivary T. denticola concentrations. In the present study, only low levels of active 
neutrophilic MMP-8 were found in saliva of LP1 group in comparison to the generalized 
periodontitis and control groups. This might be explained by the bacterial degradation of 
MMP-8 in initial periodontitis (here: in subjects with 2 pocket teeth). The released MMP-8, 
which is at low levels during initial periodontitis, can be subjected to bacterial proteases and 
get degraded (Sorsa et al., 1992; Nieminen et al., 2017). Active neutrophilic MMP-8 levels of 
LP2 and GP groups were higher than those of LP1, but at the same time similar to that of 
controls. This outcome might be explained by the simultaneous elevations of neutrophilic 
MMP-8 and bacterial proteases with the extension of the disease. In the present study, the 
gradual extension of periodontal disease from localized to generalized disease leads to 
consistently increased levels of low molecular size (20-27 kDa) fragments of MMP-8 and the 
ROC curve analysis results supported this statement. Our findings on salivary MMP-8 
fragments suggest that their levels increase with the progression of periodontitis and stay at 
elevated levels during extension of the disease. Indeed, it seems that full-size pro-form MMP-
8 is ready for a potential activation and fragmentation upon periodontal disease initiation and 
progression, and the occurrence of elevated levels of MMP-8 fragments is an outcome of this 
extended MMP-8 activation. In fact, corresponding MMP-8 activation and fragmentation 
cascades have been described during neutrophilic degranulation in vitro (Hasty et al., 1986; 
Reynaud af Geijersstam et al., 2005) and in vivo in other body fluids and secretions, such as 
diabetic nephropathic urine, glaucoma-affected tear fluid, and bronchiectasis-affected 
bronchoalveolar lavage (Prikk et al., 2002; Määttä et al., 2006; Lauhio et al., 2008). The most 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
common methods to detect MMP-8 in body fluids are the enzyme-linked immunosorbent 
assay and time-resolved immunofluorometric assay (IFMA). These two methods measure 
total MMP-8 levels, or latent and active forms of MMP-8, alone or together (Sorsa et al., 
2016; Sorsa et al., 2017). The only method to analyze molecular forms and/or fragments of 
MMP-8 is the computer-scanned western-immunoblots (Kiili et al., 2003; Hernandez et al., 
2010; Buduneli et al., 2011). The computer-quantitated western-immuoblots and IFMA have 
been demonstrated to correlate significantly with each other, indicating that both 
immunotechniques are suitable for oral fluid MMP-8 analyses (Buduneli et al., 2011). The 
ROC curve analysis obtained by computer-scanned immunoblots provided AUC scores of 
>0.7 for 20-27 kDa salivary MMP-8 fragments, which corresponds to those previously 
obtained by MMP-8 IFMA analysis (Gursoy et al., 2010; Mauramo et al., 2017).  
In the present study, no clear differences were found in the levels of pro and active forms of 
mesenchymal MMP-8 between the control and periodontitis groups. The main source of 
mesenchymal MMP-8 in saliva is fibroblasts, but other cells (odontoblasts) can secrete this 
MMP-8 isoform as well (Palosaari et al., 2000). Fibroblasts take part in tissue regeneration by 
producing new collagen and destroying the old one; fibroblastic MMP-8, together with 
MMP-1 and -13, are the only collagenases that can cleave native type I collagen (Krane 
1995). Bacterial infection connected to periodontitis affects immune cells and resident cells 
in opposite directions. While infection induces neutrophilic chemotaxis and release or 
selective degranulation of proteases in an uncontrolled manner (Scott and Krauss 2012), 
bacterial lipopolysaccharide induces apoptosis of fibroblasts (Alikhani et al., 2003). Increase 
in apoptotic behavior of fibroblasts may explain why fibroblastic (mesenchymal) MMP-8 did 
not differ between the periodontal groups in our study. Furthermore, upon activation, this 
isoform of MMP-8 can be fragmented into low molecular weight fragments (Hanemaaijer et 
al., 1997). 
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Based on the present findings, generalized periodontitis patients with elevated fragmented 
forms of salivary MMP-8 have deepened probing pocket depths after 10 years. To our 
knowledge, this is one of the first studies to demonstrate the predictive capability of salivary 
biomarkers in a longitudinal design over 10 years. 
In conclusion, fragments of MMP-8 resulting from its activation become detectable in saliva 
at initial phases of periodontitis and can be considered a possible biomarker of periodontitis. 
Future diagnostic adjunctive quantitative MMP-8 point-of-care/chair-side technologies need 
to utilize MMP-8 antibodies selective for MMP-8 activation cascade and fragments.  
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Figure legends 
Figure 1: In vitro activation and fragmentation of human proMMP-8 by Td-CTLP, NaOCl 
and APMA. The 85 kDa human recombinant proMMP-8 was incubated with Treponema 
denticola chymotrypsin-like protease (Td-CTLP) for indicated time periods (Fig 1A), oxidant 
1mM NaOCl (Fig 1B) and organomercurial 1 mM APMA (Fig 1C), and these activations and 
related fragmentations were monitored by western-immunoblotting.  Treponemal protease, 
oxidant NaOCL, and organomercurial APMA time-dependently activated and fragmented 
human proMMP-8 (Figs 1A-C). 
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Figure 2: Western-immunoblot analysis of salivary samples studied for molecular forms, 
degree of activation and related fragmentation of MMP-8. Lanes 1-2: control - ; lanes 3-4: 
LP1; lanes 5-6: LP2; lanes 7-8:  GP. Lane 9 indicates neutrophilic (PMN) proMMP-8 
(pMMP-8), active PMN MMP-8 (aMMP-8) and fragments (frag.) 
Figure 3: Salivary levels of molecular forms and fragments of MMP-8 in subjects with 
generalized periodontitis [14 or more teeth with ≥4 mm probing pocket depth (PPD)], 
localized periodontitis (LP1: 2 teeth with ≥4 mm PPD and LP2: 7 teeth with ≥4mm PPD) and 
in subjects without pocket teeth (control). Significant differences between the groups were 
given as connecter lines and p-values. 
Figure 4: Receiver operating characteristics (ROC) analysis of each salivary form and 
fragment of MMP-8, in regard to periodontal disease. Area under the curve (AUC), 95% 
confidence intervals, and p-values were given by the ROC curves.  
Figure 5: After categorizing the Health 2000 survey participants according to their MMP-8 
levels in different molecular forms, their number of teeth with ≥6 mm probing pocket depth 
(PPD) in 2011 are given as box plots. Only fragmented MMP-8 gave significant differences 
within the GP group. Statistical differences are marked with connector lines and p-values.  
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